Annual SG&A
$12.23 M
+$3.41 M+38.71%
31 December 2023
Summary:
PaxMedica Common Stock annual selling, general & administrative expenses is currently $12.23 million, with the most recent change of +$3.41 million (+38.71%) on 31 December 2023. During the last 3 years, it has risen by +$7.60 million (+164.20%). PXMD annual SG&A is now at all-time high.PXMD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.49 M
-$1.81 M-54.84%
01 June 2024
Summary:
PaxMedica Common Stock quarterly selling, general & administrative expenses is currently $1.49 million, with the most recent change of -$1.81 million (-54.84%) on 01 June 2024. Over the past year, it has dropped by -$936.80 thousand (-38.62%). PXMD quarterly SG&A is now -68.58% below its all-time high of $4.74 million, reached on 31 December 2022.PXMD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$212.58 M
-$17.66 M-9.06%
01 June 2024
Summary:
PaxMedica Common Stock TTM selling, general & administrative expenses is currently -$212.58 million, with the most recent change of -$17.66 million (-9.06%) on 01 June 2024. Over the past year, it has dropped by -$226.33 million (-1646.25%). PXMD TTM SG&A is now -18310.20% below its all-time high of $13.75 million, reached on 30 September 2023.PXMD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PXMD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.7% | -38.6% | -1646.3% |
| 3 y3 years | +164.2% | +16.6% | -4002.5% |
| 5 y5 years | - | +4999.3% | -10000.0% |
PXMD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +164.2% | -68.6% | +91.9% | -527.4% | at low |
| 5 y | 5 years | at high | >+9999.0% | -68.6% | +4999.3% | <-9999.0% | at low |
| alltime | all time | at high | >+9999.0% | -68.6% | >+9999.0% | <-9999.0% | at low |
PaxMedica Common Stock Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $1.49 M(-54.8%) | $10.43 M(-10.9%) |
| Mar 2024 | - | $3.30 M(+2.4%) | $11.71 M(-4.2%) |
| Dec 2023 | $12.23 M(+38.7%) | $3.22 M(+32.8%) | $12.23 M(-11.0%) |
| Sept 2023 | - | $2.43 M(-12.4%) | $13.75 M(+0.4%) |
| June 2023 | - | $2.77 M(-27.4%) | $13.69 M(+17.0%) |
| Mar 2023 | - | $3.81 M(-19.5%) | $11.70 M(+32.7%) |
| Dec 2022 | $8.82 M(+77.3%) | $4.74 M(+100.2%) | $8.82 M(+63.3%) |
| Sept 2022 | - | $2.37 M(+205.1%) | $5.40 M(+25.3%) |
| June 2022 | - | $776.00 K(-16.9%) | $4.31 M(-6.7%) |
| Mar 2022 | - | $933.80 K(-29.4%) | $4.62 M(-7.1%) |
| Dec 2021 | $4.97 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $1.32 M(+3.5%) | $4.97 M(-8.7%) |
| Sept 2021 | - | $1.28 M(+17.5%) | $5.45 M(-0.4%) |
| June 2021 | - | $1.09 M(-15.5%) | $5.47 M(-6.3%) |
| Mar 2021 | - | $1.29 M(-28.3%) | $5.84 M(+26.1%) |
| Dec 2020 | $4.63 M(+3942.9%) | $1.80 M(+38.1%) | $4.63 M(+63.4%) |
| Sept 2020 | - | $1.30 M(-10.5%) | $2.83 M(+84.9%) |
| June 2020 | - | $1.45 M(+1729.7%) | $1.53 M(+1310.9%) |
| Mar 2020 | - | $79.40 K(+171.9%) | $108.60 K(+194.3%) |
| Dec 2019 | $114.50 K | - | - |
| June 2019 | - | $29.20 K(+279.2%) | $36.90 K(+379.2%) |
| Mar 2019 | - | $7700.00 | $7700.00 |
FAQ
- What is PaxMedica Common Stock annual selling, general & administrative expenses?
- What is the all time high annual SG&A for PaxMedica Common Stock?
- What is PaxMedica Common Stock annual SG&A year-on-year change?
- What is PaxMedica Common Stock quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for PaxMedica Common Stock?
- What is PaxMedica Common Stock quarterly SG&A year-on-year change?
- What is PaxMedica Common Stock TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for PaxMedica Common Stock?
- What is PaxMedica Common Stock TTM SG&A year-on-year change?
What is PaxMedica Common Stock annual selling, general & administrative expenses?
The current annual SG&A of PXMD is $12.23 M
What is the all time high annual SG&A for PaxMedica Common Stock?
PaxMedica Common Stock all-time high annual selling, general & administrative expenses is $12.23 M
What is PaxMedica Common Stock annual SG&A year-on-year change?
Over the past year, PXMD annual selling, general & administrative expenses has changed by +$3.41 M (+38.71%)
What is PaxMedica Common Stock quarterly selling, general & administrative expenses?
The current quarterly SG&A of PXMD is $1.49 M
What is the all time high quarterly SG&A for PaxMedica Common Stock?
PaxMedica Common Stock all-time high quarterly selling, general & administrative expenses is $4.74 M
What is PaxMedica Common Stock quarterly SG&A year-on-year change?
Over the past year, PXMD quarterly selling, general & administrative expenses has changed by -$936.80 K (-38.62%)
What is PaxMedica Common Stock TTM selling, general & administrative expenses?
The current TTM SG&A of PXMD is -$212.58 M
What is the all time high TTM SG&A for PaxMedica Common Stock?
PaxMedica Common Stock all-time high TTM selling, general & administrative expenses is $13.75 M
What is PaxMedica Common Stock TTM SG&A year-on-year change?
Over the past year, PXMD TTM selling, general & administrative expenses has changed by -$226.33 M (-1646.25%)